Oracle Healthcare Acquisition Corp. (OHAQ) Stock Analysis

Oracle Healthcare Acquisition Corp. (OHAQ) Healthcare & Pipeline Overview

Oracle Healthcare Acquisition Corp., a SPAC founded in 2005, is actively seeking a merger, asset acquisition, or other business combination within the healthcare sector, targeting healthcare services, medical devices, healthcare IT, pharmaceuticals, and life sciences, but currently has no significant operations.

What Is the Investment Thesis for OHAQ?

Oracle Healthcare Acquisition Corp. presents a speculative investment opportunity tied to its ability to identify and successfully merge with a promising healthcare company. The company's success hinges on the management team's expertise in deal sourcing and execution within the healthcare sector. Key value drivers include the attractiveness of the target company, the terms of the merger agreement, and the post-merger performance of the combined entity. The absence of current operations makes traditional financial analysis challenging, with the focus instead on assessing the team's capabilities and the potential market opportunity of the target sector. The company's profit margin is 120.8% and gross margin is 100.0%. A potential catalyst is the announcement of a definitive agreement with a target company, while risks include the failure to find a suitable target or unfavorable market conditions impacting the healthcare industry.

Based on FMP financials and quantitative analysis

OHAQ Key Highlights

Oracle Healthcare Acquisition Corp. operates as a special purpose acquisition company (SPAC) targeting the healthcare industry.

• The company's objective is to merge with or acquire an existing operating business in healthcare services, medical devices, healthcare IT, pharmaceuticals, or life sciences.
• Founded in 2005, Oracle Healthcare Acquisition Corp. is headquartered in Greenwich, Connecticut.
• The company's high profit margin of 120.8% and gross margin of 100.0% reflect its current state as a SPAC without significant operating expenses.
• The company's beta of -9.48 suggests an inverse correlation with the overall market, but may not be reliable due to the company's lack of operations.

Who Are OHAQ's Competitors?

OHAQ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OHAQ's Key Strengths?

Dedicated capital for acquisitions.

• Focus on the high-growth healthcare sector.
• Experienced management team (assumed).

What Are OHAQ's Weaknesses?

No current operations or revenue.

• Dependent on identifying and acquiring a suitable target.
• Competition from other SPACs and private equity firms.

What Could Drive OHAQ Stock Higher?

Announcement of a definitive agreement to acquire a target company in the healthcare sector.

• Completion of due diligence and regulatory approvals for the proposed acquisition.
• Successful integration of the acquired company and realization of synergies.
• General market sentiment towards healthcare investments and SPACs.
• Management team's ability to identify and execute value-creating acquisitions.

What Are the Key Risks for OHAQ?

Financial-distress signal — its Altman Z-Score of 0.17 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Insider selling — insiders were net sellers of roughly $15.7M recently.
• Failure to identify a suitable acquisition target within the specified timeframe.
• Unfavorable terms in the acquisition agreement that could dilute shareholder value.
• Regulatory hurdles or legal challenges that could delay or prevent the acquisition.
• Market volatility and economic uncertainty impacting the healthcare industry.
• Competition from other SPACs and private equity firms for attractive acquisition targets.

What Are the Growth Opportunities for OHAQ?

• Acquisition of a Healthcare Services Company: Oracle Healthcare Acquisition Corp. could target a healthcare services company specializing in telemedicine, home healthcare, or specialized clinics. The market for telemedicine is projected to reach $460 billion by 2030, offering significant growth potential. Successful integration and expansion of the acquired company could drive substantial returns for investors. The timeline for this growth opportunity is dependent on identifying and closing a deal, which could occur within the next 12-24 months.
• Merger with a Medical Device Manufacturer: The company could pursue a merger with a medical device manufacturer focused on innovative technologies such as robotic surgery, minimally invasive procedures, or remote patient monitoring. The global medical device market is expected to reach $600 billion by 2028, presenting a large and growing market opportunity. Successful commercialization of new devices and expansion into new markets could drive revenue growth. This opportunity could materialize within the next 18-36 months.
• Investment in a Healthcare IT Company: Oracle Healthcare Acquisition Corp. could invest in a healthcare IT company specializing in electronic health records (EHR), data analytics, or cybersecurity solutions. The healthcare IT market is projected to reach $390 billion by 2027, driven by the increasing adoption of digital health technologies. Successful integration of the acquired company's solutions into existing healthcare systems could generate recurring revenue streams. This opportunity could be realized within the next 12-24 months.
• Acquisition of a Pharmaceutical Company: The company could target a pharmaceutical company focused on developing and commercializing novel therapies for chronic diseases, oncology, or rare diseases. The global pharmaceutical market is expected to reach $1.5 trillion by 2027, offering significant growth potential. Successful clinical trials and regulatory approvals could drive substantial value creation. This opportunity could materialize within the next 24-48 months.
• Investment in a Biotechnology Company: Oracle Healthcare Acquisition Corp. could invest in a biotechnology company specializing in gene therapy, personalized medicine, or regenerative medicine. The biotechnology market is projected to reach $1 trillion by 2028, driven by advancements in genomics and precision medicine. Successful development and commercialization of innovative therapies could generate significant returns for investors. This opportunity could be realized within the next 24-48 months.

What Opportunities Does OHAQ Have?

• Acquire a high-growth healthcare company.
• Capitalize on favorable industry trends.
• Generate significant returns for shareholders.

What Are OHAQ's Competitive Advantages?

• The company's moat, if any, depends on the expertise and track record of its management team.
• Access to capital raised through the IPO provides a competitive advantage in pursuing acquisition opportunities.
• The company's focus on the healthcare industry allows it to develop specialized knowledge and networks.

What Does OHAQ Do?

Oracle Healthcare Acquisition Corp. was established in 2005 and is based in Greenwich, Connecticut. The company operates as a special purpose acquisition company (SPAC), also known as a blank check company. Its primary objective is to identify and acquire an existing operating business within the broad healthcare industry. Oracle Healthcare Acquisition Corp. intends to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company's search for a target acquisition is not limited to a specific geographic region or market capitalization, providing flexibility in its approach. The company focuses its search for an acquisition candidate in segments such as healthcare services, medical devices and products, healthcare information technology, pharmaceuticals, diagnostics, biotechnology therapeutics, and life sciences. As of March 18, 2026, Oracle Healthcare Acquisition Corp. does not have significant operations, as it is still in the process of identifying and completing its initial business combination.

What Products and Services Does OHAQ Offer?

• Oracle Healthcare Acquisition Corp. is a special purpose acquisition company (SPAC).
• The company's primary purpose is to identify and acquire an operating business in the healthcare industry.
• They seek to complete a merger, capital stock exchange, asset acquisition, or similar business combination.
• The company focuses on healthcare services, medical devices, healthcare IT, pharmaceuticals, diagnostics, biotechnology, and life sciences.
• They do not currently have significant operations.
• The company is actively searching for a suitable acquisition target.

How Does OHAQ Make Money?

• Oracle Healthcare Acquisition Corp. raises capital through an initial public offering (IPO).
• The company uses the IPO proceeds to fund its search for an acquisition target.
• The business model relies on the management team's expertise in identifying and evaluating potential acquisition targets.
• Upon completing an acquisition, the company's business model will shift to that of the acquired company.

What Industry Does OHAQ Operate In?

Oracle Healthcare Acquisition Corp. operates within the dynamic and competitive healthcare industry. The healthcare sector is experiencing significant growth, driven by factors such as an aging population, technological advancements, and increasing demand for healthcare services. The SPAC structure allows companies like Oracle Healthcare Acquisition Corp. to quickly enter the market and capitalize on these trends. However, the competitive landscape is intense, with numerous SPACs and private equity firms vying for attractive healthcare assets. Success depends on identifying undervalued or high-growth potential targets.

Who Are OHAQ's Key Customers?

• Oracle Healthcare Acquisition Corp.'s initial customers are its shareholders.
• The company aims to deliver value to its shareholders by identifying and acquiring a successful healthcare business.
• The future customers will be those of the acquired healthcare company.

Return on equity for Oracle Healthcare Acquisition Corp. stands at 9.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.2%, showing how much profit it generates from its asset base. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Oracle Healthcare Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Greenwich, US. The company is led by CEO Larry Neil Feinberg. OHAQ has traded publicly since 2006.

Oracle Healthcare Acquisition Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.17 places it in the distress zone, a signal of elevated financial risk.

The most recent 11 insider filings for Oracle Healthcare Acquisition Corp. break down as 1 sales and 10 purchases. On net that is roughly 1.9M shares disposed (about $15.7M), a signal worth weighing alongside the fundamentals.

OHAQ Financials

OHAQ Latest News

No recent news available for OHAQ.

OHAQ Analyst Consensus

OHAQ MoonshotScore

Oracle Healthcare Acquisition Corp. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources